Patient Square Capital LP Liquidia Corp Transaction History
Patient Square Capital LP
- $215 Billion
- Q2 2024
A detailed history of Patient Square Capital LP transactions in Liquidia Corp stock. As of the latest transaction made, Patient Square Capital LP holds 7,182,532 shares of LQDA stock, worth $72 Million. This represents 40.01% of its overall portfolio holdings.
Number of Shares
7,182,532
Previous 7,182,532
-0.0%
Holding current value
$72 Million
Previous $106 Billion
18.64%
% of portfolio
40.01%
Previous 45.11%
Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
158Shares Held
36MCall Options Held
1.79MPut Options Held
380K-
Black Rock Inc. New York, NY4.24MShares$42.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$34.1 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.4MShares$24.1 Million13.89% of portfolio
-
State Street Corp Boston, MA2.23MShares$22.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.06MShares$20.6 Million0.12% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $646M
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...